NCT03652220

Brief Summary

To evaluate effectiveness of a 8-week behavioral Mind-Body-Intervention based on Yoga and Meditation in depressive outpatients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
81

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 22, 2018

Completed
5 days until next milestone

Study Start

First participant enrolled

August 27, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 29, 2018

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 20, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 20, 2020

Completed
Last Updated

July 27, 2022

Status Verified

July 1, 2022

Enrollment Period

1.9 years

First QC Date

August 22, 2018

Last Update Submit

July 25, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change of Beck Depression Index BDI-II

    Change of depressive Symptoms

    Baseline, 4 weeks, 8 weeks. Follow-up 24 weeks

Secondary Outcomes (19)

  • Freiburg Mindfulness Inventory (FMI)

    Baseline, 8 weeks; Follow-up 24 weeks

  • Mindful Attention Awareness Scale (MAAS)

    Baseline, 8 weeks; Follow-up 24 weeks

  • Perceived Stress Scale (PSS-10)

    Baseline, 8 weeks; Follow-up 24 weeks

  • Brief Symptom Checklist (BSI-18)

    Baseline, 8 weeks; Follow-up 24 weeks

  • Aachen Self-Efficacy Questionnaire (Aachener Selbstwirksamkeitsfragebogen, [ASF])

    Baseline, 8 weeks; Follow-up 24 weeks

  • +14 more secondary outcomes

Study Arms (3)

Intervention

EXPERIMENTAL

8 weeks Minimal treatment + MBLM 16 weeks Multimodal specific treatment + MBLM Consolidation Definitions Minimal treatment: drug continuation under medical supervision Multimodal specific treatment: Drugs / Psychotherapy / Excercise therapy / Ergotherapy / Relaxation; excl. Yoga, Mantra, MBSR MBLM: 8-week course Meditation Based Lifestyle Modification MBLM-Consolidation: weekly Mantra-Meditation, monthly Life-Ethics

Behavioral: Meditation Based Lifestyle Modification

Control I

ACTIVE COMPARATOR

8 weeks Minimal treatment 16 weeks Multimodal specific treatment Definitions Minimal treatment: drug continuation under medical supervision Multimodal specific treatment: Drugs / Psychotherapy / Excercise therapy / Ergotherapy / Relaxation; excl. Yoga, Mantra, MBSR MBLM: 8-week course Meditation Based Lifestyle Modification MBLM-Consolidation: weekly Mantra-Meditation, monthly Life-Ethics

Other: Minimal treatmentOther: Multimodal specific treatment:

Control 2

ACTIVE COMPARATOR

Definitions 24 weeks Multimodal specific treatment Minimal treatment: drug continuation under medical supervision Multimodal specific treatment: Drugs / Psychotherapy / Excercise therapy / Ergotherapy / Relaxation; excl. Yoga, Mantra, MBSR MBLM: 8-week course Meditation Based Lifestyle Modification MBLM-Consolidation: weekly Mantra-Meditation, monthly Life-Ethics

Other: Multimodal specific treatment:

Interventions

8 weekly modules, each 3.5 hours of Life ethics, Yoga exercises and Mantra Meditation

Intervention

Drug continuation under medical supervision

Control I

Drugs / Psychotherapy / Excercise therapy / Ergotherapy / Relaxation; excl. Yoga, Mantra, MBSR

Control 2Control I

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects must meet the following criteria to be enrolled:
  • Outpatients
  • Written informed consent by patients who are competent to consent to study participation
  • Diagnosis of current mild or moderate episode of depression diagnosed by a consultant psychiatrist
  • Male or female ≥18 years of age
  • BDI-II \>= 10
  • Patients must be physically able to perform simple Yoga postures and to sit silently for 20 minutes

You may not qualify if:

  • Patients will be excluded for ANY ONE of the following reasons:
  • Psychotic Symptoms
  • Acute suicidal tendencies
  • Compulsive disorders
  • Cerebro-organic diseases with clinically relevant symptoms
  • Severe multimorbidity
  • Clinically relevant addictions (tobacco abuse or addiction is allowed)
  • Current participation in another trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Diakoniekliniken Zschadraß

Colditz, Saxony, 04680, Germany

Location

Related Publications (2)

  • Bringmann HC, Berghofer A, Jeitler M, Michalsen A, Brunnhuber S, Haller H. Meditation-Based Lifestyle Modification in Mild-to-Moderate Depression: Outcomes and Moderation Effects of Spirituality. J Integr Complement Med. 2024 Jun;30(6):532-542. doi: 10.1089/jicm.2023.0179. Epub 2023 Nov 27.

  • Bringmann HC, Vennemann J, Gross J, Matko K, Sedlmeier P. "To Be Finally at Peace with Myself": A Qualitative Study Reflecting Experiences of the Meditation-Based Lifestyle Modification Program in Mild-to-Moderate Depression. J Altern Complement Med. 2021 Sep;27(9):786-795. doi: 10.1089/acm.2021.0038. Epub 2021 Jun 29.

MeSH Terms

Conditions

Depressive Disorder

Condition Hierarchy (Ancestors)

Mood DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a three-arm, randomized, active-controlled, unblinded, parallel, exploratory study to compare the outcome in depression between standard specific treatment, multimodal specific treatment and standard treatment plus MBLM. After being screened for eligibility and signing the informed consent patients will be randomized 1:1:1 to either one of the groups. After being enrolled, patients in MBLM group receive an introductory education of the MBLM course and then join group sessions weekly for 8 weeks. They also see a consultant psychiatrist as needed for drug continuation therapy. Patients should practice MBLM related content at home for a proposed duration of 30-45 minutes per day. Patients in the control groups receive standard (control group I) or multimodal (control group II) treatment as administered by their consultant psychiatrist.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. med. B. Sc.

Study Record Dates

First Submitted

August 22, 2018

First Posted

August 29, 2018

Study Start

August 27, 2018

Primary Completion

July 20, 2020

Study Completion

July 20, 2020

Last Updated

July 27, 2022

Record last verified: 2022-07

Locations